A Study of LY3502970 in Participants With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT05048719. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of Once-Daily LY3502970 Compared With Placebo and Once-Weekly Dulaglutide in Participants With Type 2 Diabetes Mellitus
Study identification
- NCT ID
- NCT05048719
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 383 participants
Conditions and interventions
Conditions
Interventions
- Dulaglutide Drug
- LY3502970 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2021
- Primary completion
- Sep 29, 2022
- Completion
- Sep 29, 2022
- Last update posted
- Oct 16, 2023
2021 – 2022
United States locations
- U.S. sites
- 20
- U.S. states
- 9
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Anaheim Clinical Trials, LLC | Anaheim | California | 92801 | — |
| Velocity Clinical Research, Huntington Park | Huntington Park | California | 90255 | — |
| Velocity Clinical Research, Westlake | Los Angeles | California | 90057 | — |
| Rancho Cucamonga Clinical Research | Rancho Cucamonga | California | 91730 | — |
| Touro University California | Vallejo | California | 94592 | — |
| New West Physicians Clinical Research | Golden | Colorado | 80401 | — |
| Optumcare Colorado Springs - Monument | Monument | Colorado | 80132 | — |
| Cotton O'Neil Clinical Research Center | Topeka | Kansas | 66606 | — |
| Clinvest Research LLC | Springfield | Missouri | 65807 | — |
| Premier Research | Trenton | New Jersey | 08611 | — |
| Intend Research, LLC | Norman | Oklahoma | 73069 | — |
| Capital Area Research, LLC | Camp Hill | Pennsylvania | 17011 | — |
| Family Medical Associates | Levittown | Pennsylvania | 19056 | — |
| Tristar Clinical Investigations | Philadelphia | Pennsylvania | 19114 | — |
| Dallas Diabetes Research Center | Dallas | Texas | 75230 | — |
| Biopharma Informatic, LLC | Houston | Texas | 77084 | — |
| Bandera Family Health Care | San Antonio | Texas | 78249 | — |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | — |
| Capital Clinical Research Center | Olympia | Washington | 98502 | — |
| Eastside Research Associates | Redmond | Washington | 98052 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05048719, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 16, 2023 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05048719 live on ClinicalTrials.gov.